Shernan Holtan, MD, and Rahul Banerjee, MD, FACP, discussed various trials of significance shared as posters and presentations at the 2025 Tandem Meeting.
Shernan Holtan, MD
Advertisement
Articles by Shernan Holtan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Durvalumab Plus BCG Earns FDA Approval For High-Risk NMIBC
2
ASCO 2026: The Presentations That May Shape The Future of Multiple Myeloma
3
How the Landscape of GI Oncology is Evolving: A 2026 ASCO Preview
4
What Are The Top Lymphoma Abstracts at ASCO 2026?
5